Viewing Study NCT06532032


Ignite Creation Date: 2025-12-24 @ 9:35 PM
Ignite Modification Date: 2026-01-02 @ 10:49 AM
Study NCT ID: NCT06532032
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-12-05
First Post: 2024-07-29
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Combination Therapy With Amivantamab and Docetaxel in Participants With Metastatic Non-small Cell Lung Cancer
Sponsor: Janssen Research & Development, LLC
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module